Abiopharma

Net Asset Value(s)

Annual Reports and Related Documents:

General Announcement: Update on Termination of Contract

Change in holdings of interested parties/officers

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest of Director and Chief Executive Officer - Ravinder Sajwan

General Announcement: J.P. Morgan ASEAN Real Assets Forum (30 June 2026)

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR

Annual General Meeting :

Change in holdings of interested parties/officers - Steve Moore